[Delayed anastomotic dehiscence in advanced colorectal cancer treated with Bevacizumab™].
Carlos
C
Placer
Izaskun
I
Markinez
Araceli
A
Rodríguez
Jose Luis
JL
Elósegui
Jose María Enríquez
JM
Navascués
D000230:Adenocarcinoma / Q000601:surgery*; D000368:Aged; D000714:Anastomosis, Surgical; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D013529:Surgical Wound Dehiscence / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab